Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)

View source ↗

Summary

A patient-preference clinical trial is evaluating hydroxychloroquine versus methotrexate for frontal fibrosing alopecia in routine clinical care; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Frontal Fibrosing Alopecia, Cicatricial Alopecia | Status: NOT_YET_RECRUITING